Published in Intensive Care Med on November 30, 2002
Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb (2003) 4.44
WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. Blood (2004) 2.41
Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke (2009) 2.30
Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model. Anesthesiology (2012) 2.25
Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis. Haematologica (2004) 1.82
Myocardial lactate deprivation is associated with decreased cardiovascular performance, decreased myocardial energetics, and early death in endotoxic shock. Intensive Care Med (2007) 1.67
Activated protein C improves lipopolysaccharide-induced cardiovascular dysfunction by decreasing tissular inflammation and oxidative stress. Crit Care Med (2009) 1.61
C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytes. Thromb Haemost (2008) 1.53
Inter-individual variability of effect of 7 low molecular weight antithrombin-dependent anticoagulants studied in vitro with calibrated automated thrombography. Thromb Res (2010) 1.45
A comparison of epinephrine only, arginine vasopressin only, and epinephrine followed by arginine vasopressin on the survival rate in a rat model of anaphylactic shock. Anesthesiology (2007) 1.43
Anaphylactic shock: a form of distributive shock without inhibition of oxygen consumption. Anesthesiology (2005) 1.40
Multiple myeloma with unusual inclusions. Br J Haematol (2008) 1.39
Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions. Eur J Hum Genet (2008) 1.14
Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7). Eur J Cardiothorac Surg (2011) 1.09
Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: an international multicentre study. Thromb Res (2012) 1.05
A new sensitive assay reveals that hemoglobin is oxidatively modified in vivo. Free Radic Biol Med (2005) 1.04
Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression. Exp Hematol (2010) 1.01
Ascorbate removes key precursors to oxidative damage by cell-free haemoglobin in vitro and in vivo. Biochem J (2006) 1.00
Laboratory identification of cryoglobulinemia from automated blood cell counts, fresh blood samples, and blood films. Am J Clin Pathol (2002) 0.99
In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits. Circulation (2002) 0.98
Spectrum of the mutations in Bernard-Soulier syndrome. Hum Mutat (2014) 0.97
Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin. Blood (2006) 0.97
Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies? Tissue Eng Part B Rev (2014) 0.94
C-reactive protein (CRP) increases VEGF-A expression in monocytic cells via a PI3-kinase and ERK 1/2 signaling dependent pathway. Atherosclerosis (2008) 0.94
Platelet satellitism and lympho-agglutination as presenting finding in marginal zone B-cell lymphoma. Eur J Haematol (2009) 0.91
Developments towards tissue-engineered, small-diameter arterial substitutes. Expert Rev Med Devices (2008) 0.91
Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant. Arch Intern Med (2002) 0.90
Perioperative platelet transfusion: recommendations of the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS) 2003. Can J Anaesth (2005) 0.90
Oral bioavailability of a low molecular weight heparin using a polymeric delivery system. J Control Release (2006) 0.90
Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study. Br J Haematol (2007) 0.88
Endothelial cell--interactions with polyelectrolyte multilayer films. Biomaterials (2005) 0.87
Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants. Thromb Haemost (2003) 0.87
Enhancement of the inducible NO synthase activation by retinoic acid is mimicked by RARalpha agonist in vivo. Am J Physiol Endocrinol Metab (2002) 0.86
Retinoic acid amplifies the host immune response to LPS through increased T lymphocytes number and LPS binding protein expression. Mol Cell Endocrinol (2005) 0.86
Oxygen binding and oxidation reactions of human hemoglobin conjugated to carboxylate dextran. Biochim Biophys Acta (2004) 0.85
Recombinant human activated protein C improves endotoxemia-induced endothelial dysfunction: a blood-free model in isolated mouse arteries. Am J Physiol Heart Circ Physiol (2009) 0.85
Frequency of thrombocytopenia and large platelets correlates neither with conotruncal cardiac anomalies nor immunological features in the chromosome 22q11.2 deletion syndrome. Eur J Pediatr (2004) 0.85
The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation. Transpl Immunol (2011) 0.85
Tissue factor pathway inhibitor: a new link among arterial stiffness, pulse pressure, and coagulation in postmenopausal women. Arterioscler Thromb Vasc Biol (2011) 0.85
Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study. Thromb Res (2013) 0.85
Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis. Arch Cardiovasc Dis (2011) 0.84
Phenotyping the haemostatic system by thrombography--potential for the estimation of thrombotic risk. Thromb Res (2004) 0.84
O2 level controls hematopoietic circulating progenitor cells differentiation into endothelial or smooth muscle cells. PLoS One (2009) 0.84
T-cell immune constitution after peripheral blood mononuclear cell transplantation in complete DiGeorge syndrome. Br J Haematol (2002) 0.83
Small vessel replacement by human umbilical arteries with polyelectrolyte film-treated arteries: in vivo behavior. J Am Coll Cardiol (2008) 0.83
Comparative evaluation of schistocyte counting by an automated method and by microscopic determination. Am J Clin Pathol (2004) 0.83
A new method of implanting orthotopic rat bladder tumor for experimental therapies. Int J Cancer (2002) 0.82
Immune constitution monitoring after PBMC transplantation in complete DiGeorge syndrome: an eight-year follow-up. Clin Immunol (2008) 0.82
Polyelectrolyte Films Boost Progenitor Cell Differentiation into Endothelium-like Monolayers. Adv Mater (2008) 0.82
Calibrated automated thrombin generation in frozen-thawed platelet-rich plasma to detect hypercoagulability. Pathophysiol Haemost Thromb (2003) 0.81
Pharmacological and physicochemical factors in the pressor effects of conjugated haemoglobin-based oxygen carriers in vivo. J Hypertens (2007) 0.81
Inhibition of PDGFR phosphorylation and Src and Akt activity by GN963 leads to therapy of human pancreatic cancer growing orthotopically in nude mice. Int J Oncol (2006) 0.81
The importance of the effect of shear stress on endothelial cells in determining the performance of hemoglobin based oxygen carriers. Biomaterials (2008) 0.81
Poly(styrenesulfonate)/poly(allylamine) multilayers: a route to favor endothelial cell growth on expanded poly(tetrafluoroethylene) vascular grafts. Biomacromolecules (2007) 0.81
[Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report]. Ann Biol Clin (Paris) (2011) 0.80
Anticoagulant activity of heparin following oral administration of heparin-loaded microparticles in rabbits. J Pharm Sci (2002) 0.80
Finding knizocytes in a peripheral blood smear. Am J Hematol (2011) 0.79
Pellets for oral administration of low-molecular-weight heparin. Drug Dev Ind Pharm (2009) 0.79
Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort. Hum Mutat (2015) 0.79
Mechanisms of antiphospholipid-induced thrombosis: effects on the protein C system. Curr Rheumatol Rep (2009) 0.79
Transient red-blood-cell morphological anomalies after acute liver dysfunction. Eur J Haematol (2009) 0.78
Influence of polymorphonuclear leukocytes on the plasma clot formation as evaluated by thromboelastometry (ROTEM). Thromb Res (2007) 0.78
Calibrated automated thrombography demonstrates hypercoagulability in patients with idiopathic pulmonary arterial hypertension. Thromb Res (2010) 0.78
(201)Tl and (99m)Tc-MIBI retention in an isolated heart model of low-flow ischemia and stunning: evidence of negligible impact of myocyte metabolism on tracer kinetics. J Nucl Med (2002) 0.78
Endothelialized and preconditioned natural umbilical arteries with long term patency open the route for future human uses. Clin Hemorheol Microcirc (2013) 0.77
Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia. Thromb Res (2009) 0.77
Dysmegakaryopoiesis, a clue for an early diagnosis of familial platelet disorder with propensity to acute myeloid leukemia in case of unexplained inherited thrombocytopenia associated with normal-sized platelets. J Pediatr Hematol Oncol (2011) 0.77
[Biclonal or biphenotypic chronic lymphotic leukemia? An answer brought by the treatment]. Ann Biol Clin (Paris) (2011) 0.77
Effects of a new perfluorocarbon emulsion on human plasma and whole-blood viscosity in the presence of albumin, hydroxyethyl starch, or modified fluid gelatin: an in vitro rheologic approach. Transfusion (2006) 0.77
Platelet activation induced by human antibodies to interleukin-8. Blood (2002) 0.77
Efficient generation of CD34+ progenitor-derived dendritic cells from G-CSF-mobilized peripheral mononuclear cells does not require hematopoietic stem cell enrichment. J Leukoc Biol (2007) 0.77
The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies. Haematologica (2008) 0.76
Stem cells: a promising source for vascular regenerative medicine. Stem Cells Dev (2014) 0.76
The degree of resistance of erythrocyte membrane cytoskeletal proteins to supra-physiologic concentrations of calcium: an in vitro study. J Membr Biol (2014) 0.76
Severe bleeding associated with use of low molecular weight heparin and selective serotonin reuptake inhibitors. Am J Med (2002) 0.76
Influence of polyelectrolyte multilayer films on the ICAM-1 expression of endothelial cells. Cell Biochem Biophys (2006) 0.76
Practical approach to the diagnosis and management of thrombocytopenia associated with tirofiban treatment. Am J Hematol (2004) 0.75
Crucial microscopic features leading to diagnosis of cobalamin C deficiency in a new-born. Br J Haematol (2013) 0.75
The ideal small arterial substitute: Role of cell seeding and tissue engineering. Clin Hemorheol Microcirc (2007) 0.75
Antiphospholipid antibodies and risk for recurrent vascular events. JAMA (2004) 0.75
Modified Folts models in the rabbit: variations on a well worn theme. Eur J Anaesthesiol (2009) 0.75
Need for additional trials of primary prophylaxis in patients with high-risk antiphospholipid antibody profiles: comment on the article by Erkan et al. Arthritis Rheum (2008) 0.75
Hemodilution with stroma-free [correction of stoma-free] hemoglobin at physiologically maintained viscosity delays the onset of vasoconstriction. Hypertension (2004) 0.75
Hydroxyethylstarch 200 and 240 differently affect aortic distensibility but not viscosity and blood pressure upon acute isovolumic hemodilution. Clin Hemorheol Microcirc (2006) 0.75
Resuscitation of severe but brief haemorrhagic shock with PFC in rabbits restores skeletal muscle oxygen delivery and does not alter skeletal muscle metabolism. Resuscitation (2006) 0.75
Immunoadsorption of alloantibodies onto erythroid membrane antigens encapsulated into polymeric microparticles. Pharm Res (2007) 0.75
How to evaluate blood substitutes for endothelial cell toxicity. Antioxid Redox Signal (2008) 0.75
Efficacy of prothrombin complex concentrate to reverse the anticoagulant effect of the pentasaccharide fondaparinux in a rabbit model. Thromb Haemost (2010) 0.75
In vitro effects of human neutrophil cathepsin G on thrombin generation: Both acceleration and decreased potential. Thromb Haemost (2010) 0.75
Polymorphonuclear neutrophils from JAK2(V617F) positive MPD patients do not support hypercoagulability: A study with calibrated automated thrombography (CAT). Blood Cells Mol Dis (2011) 0.75